Navigation Links
Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging,Growth Conference

BOULDER, Colo.--(BUSINESS WIRE)--Jul 5, 2007 - Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the C.E Unterbeg, Towbin Emerging Growth Conference on July 10 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. -0- 
Event:          C.E Unterbeg, Towbin Emerging Growth Conference

Presenter:      Robert E. Conway, Chief Executive Officer, Array

                BioPharma

Date:           Tuesday, July 10, 2007

Time:           10:30 a.m. Eastern Time

Location:       Mandarin Oriental Hotel, New York City

Audio Webcast:  www.arraybiopharma.com

About Array BioPharma:

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life-threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

Contact

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com


'"/>




Page: 1

Related medicine technology :

1. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. The Past, Present and Future of HLA Typing
11. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/20/2009)... Nov. 20 Reportlinker.com announce...n its catalogue. ,, Blood Pressure Monitoring ...lysis ,, http://www.reportlinker.com/p016430...ts---A-World-Market-Analysis.html#utm_source=prnew...e ,, Measurement of blood pressure is not onl...
(Date:11/20/2009)... Nov. 20 Reportlinker.com announce...n its catalogue. ,, Global Markets for Assiste...portlinker.com/p0164742/Global-Markets-for-Assiste...wire&utm_medium=pr&utm_campaign=prnewswire...covers the U.S., 15 Countries in Europe and Japan....
(Date:11/20/2009)...ETING, Pa., Nov. 20 In ... questions why currently available medications des...ignored, ECRI Institute, an independent nonprofit ...e on Finasteride for Prevention of Prostate Cance...9, New York Times article, " Drugs to Deter Some...
Breaking Medicine Technology:Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3ANAVEX reports sigma receptor review published in leading journal 55513 1ANAVEX reports sigma receptor review published in leading journal 55513 2ANAVEX reports sigma receptor review published in leading journal 55513 3Home Dialysis a Good Option for Kidney Disease Patients 55509 1Home Dialysis a Good Option for Kidney Disease Patients 55509 2Sandata Selected by Volunteer State Health Plan to Manage TennCare Choices 55504 1Sandata Selected by Volunteer State Health Plan to Manage TennCare Choices 55504 2
...o be Presented at the European League Against Rheu... Benefit of ofatumumab,in Patients With Rheumatoid...vania and COPENHAGEN,Denmark, June 15, 2007 /PRNe...mab A/S (CSE: GEN) announced today positive primar...ented at EULAR,2007, the Annual European Congress ...
...a from 741-patient trial show those treated with,P... blood pressure,compared to ibuprofen[1] , * Many ...pressure; even small changes in blood pressure can...roved in more than 50 countries and currently unde..., BASEL, Switzerland, June 15, 2007 - Patients wit...
Other Medicine Technology:GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6
(Date:11/20/2009)...increased food insecurity as many face problem of ...re/ -- Project Bread, the state,s leading anti-hun...ng annual status report on hunger in the Commonwea...rt, caused by high unemployment, point to 554,000 ... Food insecurity has found its way into middle cla...
(Date:11/20/2009)...v. 20 Omnicell, Inc. (Na...ns to acute healthcare facilities, announced today...r Jaffray Healthcare Conference at the New York P...ers: Randall A. Lipps, founder, chairman, preside...O ,, Date: Tuesday, December 1, 2009 ,, T...
(Date:11/20/2009)... The Louisiana Associa...sianians could experience higher health care premi...ered by Congress should become law. ,, Accordin..."Louisiana health plans have supported comprehensi...ational debate. Our plans have offered significan...
(Date:11/20/2009)...ire-USNewswire/ -- The Senate,s newly released hea...e Care Act") infringes on Americans, health-insura... president of the Institute for Health Freedom (IH... ,, The bill would (among many other provision...buy government-sanctioned health insurance; Incr...
(Date:11/20/2009)...20 Heritage Provider Network, and ... announce that as of November 6, 2009, Lakeside Me... entities, have been acquired by Lakeside Medical ...rst and foremost want to assure all of Lakeside,s ...o maintaining the high level of care they are used...
Breaking Medicine News(10 mins):Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2Health News:Senate Mandatory Health-Insurance Bill Infringes on Choice and Privacy 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3
...r patients who have drug-resistant forms of tuberc...osely as possible. That means monthly testing thro...with injections six days a week for the first six ...opies. That,s why MIT graduate student Joaquin Bla...
...1 Gold Partners, a premier clinical and regulator...of Larry Bell, M.D., as President, Regulatory, Qua...ll allow Gold Partners to harness Dr. Bell,s exten...ic force in developing pharmaceutical leadership. ...
...od night,s sleep can do wonders for yourself and y...w more zzz,s in bed can increase the love connecti...t from the Better Sleep Council at: http://inr.me...e and unrestricted use at http://www.mediaseed.tv...
... New Research Demonstrates That Small Gains in Me... , Orlando, FL (Vocus) Feb...alf of ConnextionsHealth has demonstrated that hea... economic factors are currently driving unpreceden...
...eb. 11 The board of directors,for Hillenbrand, In... per share,on the company,s common stock. The divi... record at the close of business on March 17, 2009...he North American death care industry,through the ...
...s Hope to Move Policymakers to "Thoughtful Dialogu...s gather today to debate the merits of the Medicar...s & Supplies (DMEPOS) competitive bidding prog... service-oriented jobs. The home oxygen community...
Other Medicine News:Health News:MIT project uses personal digital assistants to track TB data 2Health News:Gold Partners Appoints Larry Bell, M.D. President, Regulatory, Quality, Safety and Risk Management Services 2Health News:Lowering Health Insurance Member Disenrollment Can Generate Up To $100 Million In Incremental Revenue For Health Plans 2Health News:Lowering Health Insurance Member Disenrollment Can Generate Up To $100 Million In Incremental Revenue For Health Plans 3Health News:As Congress Debates Competitive Bidding Program, Home Oxygen Beneficiaries and Providers Left to Cope with 27 Percent Cut to Medicare Home Oxygen Benefit 2
...ver Guidants 20-year history, the VOYAGER RX Dilat...cessful treatment outcomes. It combines a new low ...haft,more flexible markers, and short taper balloo...s anatomy with even greater confidence, opening up...
AFP EIA Kit
...munoradiometric assay designed,for the quantitat...rum. It is,intended strictly for in vitro use in...nts to aid in the,management of patients with,...itions associated with abnormal,AFP production; ...
OV monitor (CA 125 Antigen)
Medicine Products: